Prof Tomas Kalincik
Professorial Fellow, Neurological Outcomes
Department of Medicine
670 Scholarly works
34 Projects
HIGHLIGHTS
2024
Research grants (ARC, NHMRC, MRFF)
New Paradigms in Prevention of Disability in Multiple Sclerosis
2021
Journal article
Associations of Disease-Modifying Therapies with COVID-19 Severity in Multiple Sclerosis
DOI: 10.1212/WNL.00000000000127532018
Research grants (ARC, NHMRC, MRFF)
Arc Training Centre in Cognitive Computing for Medical Technologies (Arc - Central Operating)
2018
Research Grant
Arc Training Centre in Cognitive Computing for Medical Technologies (Arc - Stream 1 & 2)
2015
Journal article
Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis
DOI: 10.1002/ana.243392014
Journal article
Fingolimod after natalizumab and the risk of short-term relapse
DOI: 10.1212/WNL.00000000000002832013
Journal article
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis
DOI: 10.1093/brain/awt281
RECENT SCHOLARLY WORKS
2026
Journal article
The use of routinely collected structural neuroimaging to identify cognitive impairment in multiple sclerosis
DOI: 10.1186/s12883-026-05085-z2026
Journal article
Plasma proteome in LGI-1 autoimmune encephalitis
DOI: 10.1186/s12974-026-03851-x2026
Journal article
A tailored cognitive behavioural therapy intervention for depression in those newly diagnosed with multiple sclerosis (ACTION-MS): A randomised, assessor-blinded, active comparator trial
DOI: 10.1016/j.jad.2026.1219172026
Journal article
Circulatory immune cell counts and clinical outcomes in multiple sclerosis relapse versus remission
DOI: 10.1016/j.jns.2026.1260662026
Journal article
Age and treatment class modify inflammatory risk after disease-modifying therapy discontinuation in older people with MS.
DOI: 10.1136/jnnp-2026-3386942026
Journal article
Causal effects of multiple sclerosis therapies in left-truncated registry data
DOI: 10.1177/135245852614599432026
Journal article
Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study
DOI: 10.1177/135245852614606582026
Journal article
Spider-MS: an individualized polyhedral prediction of multiple sclerosis prognosis
DOI: 10.1093/brain/awag047